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 Abstract: This paper has for an object study of bio-phyto-modulators benefic effects to cystic 
affections localizes to mammary, thyroid, ovarian, renal and synovial places. Using the bio-phyto-dinamic 
modulators, I have noticed the method minimize the traumatic surgery interventions. 
 
INTRODUCTION 
 
 The benefic effect of modulators to human beings was studied during many researche 
along many years. 
 It was realized a prospective study following the evolution of a series patients with 
polycystic affections and treatment was recommended for one year. 
 The patients were evaluated during January 2005 – June 2007, following only patients 
from Medicali’s Clinic Center in Timisoara. 
 
MATERIALS AND METHODS 
 
 We studied a number of 110 patients diagnosed with: 
- mammary cysts – 33 patients; 
- thyroid cysts – 12 patients; 
- ovarian cysts – 40 patients; 
- renal cysts – 22 patients; 
- synovial cysts – 5 patients. 
 The diagnoses were elaborated using allopath medicine’s top imagistic methods: 
- For mammary cysts from 33 patients, 12 had the confirmation by mammography and 
all 33 had mammary echography. These type of investigations were elaborated into 
accredited medical centers; 
- Thyroid cysts were diagnosed only using the echography. Its were evaluated the 
thyroid function by hormonal doses too; 
- Ovarian cysts were diagnosed by gynecological clinical exams and transvagina and 
abdomen echographies; 
-  Renal cysts were followed by abdominal echography; 
- synovial cysts were followed by computer tomography or magnetic resonance. 
 The treatment method means to use the DEA® for each person to use for drinks and 
food and DIEE® fixed on the body as: 
- for mammary cysts 2 modulators on each breast; 
- for thyroid cysts 2 modulators on each lob and 1 at the base of breastbone; 
- for ovarian cysts 2 modulators on the ovary’s region; 
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- for renal cysts 2 modulators on each kidney region and 1 at the base of breastbone; 
- For synovial cyst 2 modulators, one on the affected region and the other 
symmetrically, and 1 at thebase of breastbone. 
 The patients’ evolutions were evaluated at two months, six months and twelve months 
from the debut of therapy. 
  At this visits we checked: 
- evolution of  cysts’ dimensions using he same methods as first evaluation; 
- appreciation of general state of organism; 
- Appreciation of general health state. 
 
 RESULTS AND DISCUSIONS 
 
 1. Patients with mammary cysts 
 From 33 patients with mammary cysts, 21 went up for all controls, including after one 
year from the beginning of treatment. The results demonstrate improvement of general health 
state of all patients. The dimensions of cysts were, at the moment of diagnosis, between 10 
mm and 34 mm, an average of 23 mm. 
 After two months, the dimension of cysts decreased with an average of 19, 7 mm and 
after six months 12 mm. The final evaluation, after one year, emphasized the maintenance of 
six months’ results and even a minimum decrease, but no statistical influence.  
 
 2. Patients with thyroid cysts 
 From 12 patients, 4 of them had cystic determinations on both thyroid lobs and 8 only 
on one lob. The thyroid function was modified to 8 patients as follow: 6 with hypothyroidism 
and 2 with hyperthyroidism. From this group, 4 patients had euthyroidism. 
 The cysts’ dimensions were, at the moment of diagnosis, between 4 mm and 30 mm, 
an average of 17,4 mm. after two months from the debut of treatment, the dimensions 
decreased, the average being 9,4 mm to 8 mm. I mentioned that for 4 patients the thyroid 
cysts disappeared completely during the 2 months of treatment. Also, the thyroid function was 
normalized at 5 from 8 patients with thyroid dysfunctions. 
 The evolution after 6 months demonstrated the average diameter of thyroid cysts was 
6,2 mm, so an important decrease was clear, and evaluation after 1 year proved an average of 
3,9 mm to thyroid cysts. 
 
 3. Patients with ovary cysts    
 At the beginning of our study 15 patients were diagnosed with bilateral cystic 
affection and 25 with unilateral one. The maximum dimension of cysts was 65 mm; the 
average was 37, 8 mm. 
 Evaluation after 2 months was realized to 36 patients. We observed a decrease of 
menstrual turbulences, an upgrade of general state and a reduction of average dimension cysts 
to 28, 1 mm. 
 At 6 months from the beginning of treatment the evaluation showed us an average 
decrease of cysts’ dimension to 21, 9 mm and after 12 months to 18, 9 mm. 
 
 4. Patients with renal cysts 
 5 from 22 patients presented bilateral affection and 17 of them unilateral affection. 
 The maximum dimension of cysts was 65 mm and the average of diameter cysts’ 
value at the beginning of treatment was 47, 56 mm. The evaluation after 2 months of therapy 
was realized for 17 patients and showed us an average dimension of 44, 78 mm, so a little 
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difference. After 6 months, 15 patients were evaluated and the average diameter was 26, 56 
mm, so an important decrease. 
 After 12 months only 9 patients were evaluated and the results – an average of 21,2 
mm – is difficult to interpret. 
 
 5. Patient with synovial cysts 
 The 5th’’s patients presented the cysts as follow: 2 to ankle, 2 to papliteal space, 1 to 
elbow articulation. 
 From them, 3 obtained the decrease of cysts dimensions during first 2 months of 
treatment and to 1 patient the cyst disappeared completely. 
 
CONCLUSIONS 
 
 Bio-phyto-dynamic modulators’ utilization is necessary for therapy of cystic 
formations with different localizations.  
 Complementary method’s utilization would be indispensable for this type of affections 
to minimize the traumatic surgery interventions. 
 In case of mammary and thyroid cysts, the decrease of dimensions is quicker, but the 
period of therapy would remain 12 months to consolidate the results. 
 It was noticed a normalization of thyroid function to a great number of patients. 
 
